305 results on '"Olgun N"'
Search Results
2. Influence of trace metal release from volcanic ash on growth of Thalassiosira pseudonana and Emiliania huxleyi
3. Dinutuxumab Beta Plus Conventional Chemotherapy for Relapsed/Refractory High-Risk Neuroblastoma: A Single Centre Experience
4. Management of The Infant Adrenal Mass Lesion: Single Center Experience
5. High Grade Glioma of Central Nervous System: Single Center Treatment Experience
6. Bone marrow disease assessment in neuroblastoma: is it significant in patient management?
7. Evaluating Molecular Heterogeneity in Neuroblastoma With Next Generation Sequencing (On behalf of Turkish Pediatric Oncology Group)
8. Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Intermediate Risk Group Treatment Results
9. Evaluating ALK Mutations in Neuroblastoma With Next Generation Sequencing (On Behalf of Turkish Pediatric Oncology Group)
10. Determining the Effect of Retinoic Acid on PI3K/AKT and RAS/MAPK Pathways on Childhood Solid Tumors by using Western Blot
11. Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines
12. THE EFFECT OF FUCOİDAN AND CISPLATIN ON DNA DAMAGE RELATED GENES IN COCHLEAR CELLS
13. Stage 4S Neuroblastoma Experience with the TPOG Neuroblastoma Treatment Protocols 2003 and 2009; on Behalf of the Turkish Pediatric Oncology Group
14. Localized Neuroblastomas, Experience of the TPOG Neuroblastoma 2009 Protocol; On Behalf of the Turkish Pediatric Oncology Group
15. Questioning How to Define the “Ultra-High-Risk” Subgroup of Neuroblastoma Patients
16. Expressions of MicroRNA of Mixed Cellularity Hodgkin Lymphomas are Different in Paediatric and Adult Patients.
17. PD-L1 and PD-L2 mutations in paediatric Hodgkin Lymphoma: do they have any prognostic significance?
18. Long-term dental anomalies after pediatric cancer treatment in children [Kanser tedavisi gören çocuklarda uzun süre sonra görülen diş anomalileri]
19. The Effects of Cisplatin and Oleuropein on Neuroblastoma Cells
20. Localized Neuroblastoma: The 30 Years Experience of Dokuz Eylul University
21. Testis Involvement in Neuroblastoma: Report of Three Cases in the Turkish Pediatric Oncology Group Neuroblastoma Study and Review of the Literature
22. Could Manganese-Superoxide Dismutase be a Biomarker in Neuroblastoma?
23. Molecular Heterogenity in Neuroblastoma
24. Treatment of Neuroblastoma in Infants Younger than 18 Months: The 30 Years Experience of Dokuz Eylul University
25. Evaluation of Ototoxicity in Children with Head and Neck Cancer who Received Cisplatin and/or Carboplatin During Treatment
26. A 3 Year Review of a Cohort Turkish Paediatric Oncology Group (TURKPEDPGx)
27. Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?
28. Dokuz Eylul University Pediatric Oncology Group: Ewing Sarcoma Family of Tumors Experience
29. Treatment of Children with Intermediate-Risk Neuroblastoma: Dokuz Eylul University Experience
30. Central Nervous System Metastases in Neuroblastoma: Results of Turkish Pediatric Oncology Group Neuroblastoma 2009 (TPOG-NB-2009) Protocol
31. Mesenchimal Stem Cell and Cisplatin Interference in Neuroblastoma Experimental Animal Model
32. Effects of acyclovir on nitric oxide and cell death in herpesvirus type 1 and 2 infected HEp-2 cells: P1538
33. Inversely proportional relation between programmed cell death and nitric oxide responses: latency behaviour of bovine herpesvirus-1 in an epithelial like microenvironment
34. Dokuz Eylul University Treatment Experience of Neuroblastoma
35. The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma
36. Treatment Results in Pediatric Head and Neck Rhabdomyosarcomas: A Single Center Experience
37. Head and Neck Hemangiomas of Childhood: A Single Center Experience
38. In Vivo Prevention Local Effect of Cadmium of Local Recurrence in Xenograft Model of Osteosarcoma
39. the relation of microenvironment associated gene expression with risk classification in neuroblastoma
40. Effect of mesenchymal stem cells, tumour infiltrating lymphocytes and cancer stem cells in the neuroblastoma
41. Paediatric Hodgkin lymphoma A single center experience from the West Part of Turkey
42. Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients
43. Evaluation of Circulating Tumour Cell Load in Neuroblastoma (on behalf of Turkish Paediatric Oncology Group)
44. Effect of Mesenchymal Stem Cells and Tumour Infiltrating Lymphocytes on Cancer Stem Cells in Neuroblastoma (on behalf of Turkish Paediatric Oncology Group)
45. Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity
46. Assessment of the Clinical Importance of Molecular Basis of Neuroblastoma: A Proteomic Approach (on behalf of Turkish Paediatric Oncology Group)
47. Can High Risk Group be Categorized as 'High Risk' and 'Ultra-High Risk' in Neuroblastoma?(on behalf of Turkish Society of Paediatric Oncology Group)
48. Prospective, Observational Nationwide Study on Pharmacogenomics/Genetics of Childhood Cancers in a Cohort of Turkish Paediatric Oncology Group (TURKPEDPGX)
49. PO-333 Molecular heterogenity in neuroblastoma (on behalf of turkish paediatric oncology group)
50. Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.